Back
ARVIND REMEDIES LIMITED
	UNAUDITED FINANCIAL RESULTS
	FOR THE THREE MONTHS AND HALF YEAR ENDED SEPTEMBER 30, 2006
						(Rupees in Lakhs.)
	Particulars	Three months ended  30.09.2006	Three months ended   30.09.2005	Corresponding six months ended 30.09.2006	Corresponding six months ended 30.09.2005	Year ended 31.3.2006
		Unaudited	Unaudited	Unaudited	Unaudited	Audited
	Gross Sales	4196.73	3934.98	8,588.68	8,693.79	16,507.79
	Less: Excise Duty	(623.68)	(557.65)	(1,092.27)	(1,133.71)	(2,117.19)
	Net Sales	3,573.05	3,377.33	7,496.41	7,560.08	14,390.60
	Other Income	7.82	39.52	10.19	40.09	66.10
	Total Income	3,580.87	3,416.85	7,506.60	7,600.17	14,456.70
	Total expenditure :
	a)  (Increase) / Decrease in Stock	(44.45)	(154.17)	101.62	(88.75)	423.05
	b)  Materials Consumed	3177.43	3033.93	6,295.77	6,509.85	12,012.64
	c)  Staff Cost	79.81	80.01	161.93	151.43	293.97
	d)  Other expenditure	111.66	199.49	231.54	315.07	597.78
	Total (a) to (d)	3,324.45	3,159.26	6,790.86	6,887.60	13,327.44
	Gross Profit before Interest & Depreciation	256.42	257.59	715.74	712.57	1,129.26
	Interest	126.99	114.85	266.79	245.50	476.20
	Depreciation	41.74	37.86	82.95	76.28	151.25
	Profit before Tax	87.69	104.88	366.00	390.79	501.81
	Provision for Taxation
	Income Tax (Including Fringe Benefit Tax)	20.00	35.00	40.00	60.00	92.00
	Earlier years	-	0.90	-	0.90	18.57
	Deferred Tax	(11.96)	(4.00)	18.63	(10.31)	84.13
	Wealth Tax	-				0.26
	Profit / (Loss) after Tax	79.65	72.98	307.37	340.20	306.85
	Paid-up Equity Share Capital	2600.50	2600.50	2600.50	2600.50	2600.50
	(face value Re. 1/- per Share)
	Reserves excluding Revaluation Reserve	-	-	-	-	1,234.95
	Basic and Diluted Earnings Per Share (Rs.)	0.03	0.03	0.12	0.13	0.12
	Aggregate of Non-Promoter Shareholding
	Number of shares	194205340	192384990	194205340	192384990	194205340
	Percentage of Shareholding	74.68%	73.98%	74.68%	73.98%	74.68%
	Note :
	1. The Company operates only in one business segment namely  formulations.
	2. Previous period's figures have been regrouped / rearranged  wherever necessary to confirm to the current periods classification.
	3. Provision for taxation for the six months ended September 30, 2006 has been made on an estimate basis.  The actual tax liability will be determined on the basis of
	the taxable income of the Company for the year from April 1, 2006 to March 31, 2007.
	4. The above results were reviewed by the audit committee and taken on record at the meeting of the Board of Directors held on October 31, 2006
	5. During the quarter 8 investor complaints were received and disposed off.  There were no investor complaints pending for the redressal as at the
	the commencement and end of the quarter.
	Chennai - 600 084				For ARVIND REMEDIES LTD.
	Date: October 31, 2006
					Dr. B Arvind Shah
					CEO and Managing Director
							Back